Analgesic Efficacy Of Transdermal Buprenorphine For Postoperative Pain In Patients Undergoing Lumbar Discectomy

Comparison Of Analgesic Efficacy Of Transdermal Buprenorphine For Postoperative Pain With Control Group In Patients Undergoing Lumbar Discectomy - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070061

Enrollment

Registered

2024-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

Intervention1: Buprenorphine: Route- Transdermal Dose- 10mcg/hr Frequency- Applied night before surgery Control Intervention1: Inj Paracetamol: Inj Paracetamol 1g IV in intraoperative period Control

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II Age 18-60yrs Posted for lumbar discectomy

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study Patients on any other form of opioid therapy for chronic pain History of drug allergy or application

Design outcomes

Primary

Measure	Time frame
To compare postoperative VAS score in patients receiving buprenorphine patch v/s control who wont receive buprenorphine patchTimepoint: VAS score , HR , BP , SPO2 will be assessed at 0, 2, 4, 8, 12, 24 and 48hrs in both the groups and recorded	—

Secondary

Measure	Time frame
Time to first rescue analgesic. Total rescue analgesic. Timepoint: Time of first rescue analgesia, total analgesic consumption will be recorded in first 48 hours.	—

Countries

India

Contacts

Public ContactManjunath A C

Sapthagiri Institute Of Medical Sciences And Research Centre

manjumac5@gmail.com8123540084

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026